Amphetamine psychosis and schizophrenia: A dual model

https://doi.org/10.1016/0149-7634(81)90015-4Get rights and content

Abstract

Several of the behavioral consequences of acute and chronic amphetamine treatment were evaluated and related to the underlying neurochemical correlates of drug treatment. It was suggested that decreased noradrenergic activity after long-term amphetamine treatment influences stimulus sampling, whereas enhanced dopaminergic activity is responsible for the progressive augmentation of stereotypy and self-stimulation behavior observed after long-term exposure to amphetamine. It was hypothesized that amphetamine-induced psychosis and the symptomatology associated with schizophrenia are related to alterations in both norepinephrine and dopamine activity.

References (173)

  • M. Goldstein et al.

    The conversion in vivo of d-amphetamine to (+)-p-hydroxynorephedrine

    Biochem. biophys. Acta

    (1965)
  • P.M. Groves et al.

    Alteration of the effects of (+)-amphetamine on neuronal activity in the striatum following lesions of the nigrostriatal bundle

    Neuropharmacology

    (1975)
  • D.R. Howlett et al.

    Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites

    Brain Res.

    (1979)
  • H. Huberman et al.

    A slow-release silicone pellet for chronic amphetamine administration

    Eur. J. Pharm.

    (1977)
  • B.L. Jacobs et al.

    Dreams, hallucinations and psychosis: the serotonin connection

    Trends Neurosci.

    (1979)
  • P.H. Kelly et al.

    Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens, septi and corpus striatum

    Brain Res.

    (1975)
  • J.E. Kleinman et al.

    Catecholamines and metabolites in the brains of psychotics and normals: post-mortem studies

  • L. Kokkinidis et al.

    Abatement of stimulus perseveration following repeated d-amphetamine treatment: Absence of behaviorally augmented tolerance

    Pharmac. Biochem. Behav.

    (1978)
  • L. Kokkinidis et al.

    Behavior specific tolerance following chronic d- or l-amphetamine treatment: lack of involvement of p-hydroxynorephedrine

    Neuropharmacology

    (1978)
  • L. Kokkinidis et al.

    Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task

    Pharmac. Biochem. Behav.

    (1976)
  • L. Kokkinidis et al.

    Ontogenetic variations in d-amphetamine stimulus perseveration

    Behav. Neural Biol.

    (1979)
  • L. Kokkinidis et al.

    Enhanced self-stimulation responding from the substantia nigra after chronic amphetamine treatment: A role for conditioning factors

    Pharmac. Biochem. Behav.

    (1980)
  • L. Kokkinidis et al.

    Enhanced lateral hypothalamic self-stimulation responding after chronic exposure to amphetamine

    Behav. Neural Biol.

    (1980)
  • L. Kokkinidis et al.

    Post-amphetamine depression of self-stimulation responding from the substantia nigra: Reversal by tricyclic antidepressants

    Pharmac. Biochem. Behav.

    (1980)
  • G.K. Aghajanian et al.

    Action of psychotogenic drugs on single midbrain raphé neurons

    J. Pharmac. exp. Ther.

    (1970)
  • H. Anisman et al.

    Effects of scopolamine, d-amphetamine and other drugs affecting catecholamines on spontaneous alternation and locomotor activity in mice

    Psychopharmacologia

    (1975)
  • J. Axelrod

    Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine

    J. Pharmac. exp. Ther.

    (1954)
  • R.A. Barkley

    Predicting the response of hyperkinetic children to stimulant drugs: a review

    J. abnorm. Child Psychol.

    (1976)
  • R.A. Barkley et al.

    The effects of methylphenidate on the mother child interaction of hyperactive children

    Archs gen. Psychiat.

    (1979)
  • J.M. Beaton et al.

    The behavioral effects of some hallucinogenic derivatives of amphetamine

  • D.S. Bell

    Addiction to stimulants

    Med. J. Aust.

    (1967)
  • D.S. Bell

    Comparison of amphetamine psychosis and schizophrenia

    Br. J. Psychiat.

    (1965)
  • P.A. Berger et al.

    Neuroregulators and schizophrenia

  • E.D. Bird et al.

    Brain norepinephrine and dopamine in schizophrenia

    Science

    (1979)
  • E. Bleuler

    Dementia Praecox

    (1950)
  • J.A. Book et al.

    Schizophrenia in North Swedish geographical isolate. Epidemiology, genetics and biochemistry

    Clin. Genet.

    (1978)
  • M.B. Bowers et al.

    “Psychedelic” experiences in acute psychoses

    Archs gen. Psychiat.

    (1966)
  • B.B. Brodie et al.

    Possible role of p-hydroxynorephedrine in the depletion of norepinephrine induced by d-amphetamine and in tolerance to this drug

  • V. Bruto et al.

    Chronic amphetamine influences stimulus filtering

    Soc. Neurosci. Abstr.

    (1980)
  • A. Carlsson

    Amphetamine and brain catecholamines

  • J.P. Chalmers et al.

    Effects of l-Dopa on norepinephrine metabolism in the brain

  • J. Chapman

    The early symptoms of schizophrenia

    Br. J. Psychiat.

    (1966)
  • C.C. Chiueh et al.

    d-Amphetamine-induced release of newly synthesized and stored dopmine from the caudate nucleus in vivo

    J. Pharmac. exp. Ther.

    (1975)
  • P.H. Connell

    Amphetamine Psychosis

    (1958)
  • A.R. Cools

    Haloperidol and the significance of alpha-NE mediated control of a subpopulation of DA receptors for concepts such as supersensitivity and tolerance: a behavioral study on cats

    Life Sci.

    (1978)
  • E. Costa et al.

    Biosynthesis and storage of catecholamines in tissues of rats injected with various doses of d-amphetamine

  • E. Costa et al.

    Effects of amphetamine on the turnover rate of brain catecholamines and motor activity

    Br. J. Pharmac.

    (1972)
  • I. Creese et al.

    The role of forebrain dopamine systems in amphetamine-induced stereotyped behavior in the rat

    Psychopharmacologia

    (1974)
  • I. Creese et al.

    Amphetamine response in rat after dopamine neuron destruction

    Nature. New Biol.

    (1972)
  • C.R. Creveling et al.

    Substrates and inhibitors of dopamine-beta-oxidase

    Biochem. biophys. Acta

    (1965)
  • Cited by (0)

    View full text